Downregulation of NKp30 and NKp46 has been reported previously in acute myeloid leukemia and chronic lymphocytic leukemia and shown to correlate with decreased NK cell cytotoxicity (40–42). Here, NCR3 is linked to B-cell chronic lymphocytic leukemia.